Allen Zhiwei Wu, Ph.D.

CURRICULUM VITA -

Allen Zhiwei Wu Center for Public Health Research School of Medicine, Nanjing University 22 Han Ko Road, Meng Mingwei Tower Rm# 2104 Nanjing, Jiangsu 210093, P.R. China Email: [email protected], and/or [email protected]

EDUCATION: 1982: B.A., Biological Sciences, Nanjing University, Nanjing, P.R. China. 1991: Ph.D., Biochemistry, University of Edinburgh, Edinburgh, UK.

PROFESSIONAL EXPERIENCE: 2005-present: Professor and Director, Center for Public Health Research, School of Medicine, Nanjing University, Nanjing, P.R. China. 2008-present: Professor and associate director, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University. 2007-present: Adjunct associate professor, New York University, New York, USA. 2006-present: Associate, Southampton Statistical Sciences Research Institute, University of Southampton. UK. 2000-2005: Sr. Investigator, at Leon Levy Dental Research Center, Dept. of Biochemistry, School of Dental Medicine, University of Pennsylvania. 1997- 2000: Staff Scientist/Assistant professor, Center for Biomedical Research, The Population Council, Rockefeller University, NY, NY. 1994- 1997: NIH Fellow, Dept. of Microbiology, New York University Medical School, NY, NY. 1992-1994: Aaron Diamond Fellow, Public Health Research Institute, New York University Medical School, NY, NY. 1990- 1992: Postdoctoral Fellow, Public Health Research Institute, NYU Medical School, NY, NY. 1986- 1990: Ph.D., University of Edinburgh, Edinburgh, UK.

HONORS: Academic Staff Award, PRC, 1985; Overseas Research Student Award (ORS), UK, 1987-1989; Wellcome Trust Fellowship, London, UK, 1988-1989; Melville Assistantship, Scotland, UK, 1988-1989; Aaron Diamond Fellow, USA, 1992-4; NIH Fellow, USA, 1995. Nanjing Xixia Scientifc Innovation Award (321 Award) (2012) Suzhou Science and Technology Leadership Award (2014) Jiangsu Excellence in Research and Development Award (2016)

1 Dr. Prof. Anita Hardon Education 1990, PhD Medical Anthropology, University of Amsterdam 1985, MSc Medical Biology (majors: medical anthropology, epidemiology, STS) Cum Laude

Employment 2017-2018 Lead Health Systems, Institute for Advanced Studies, University of Amsterdam 2009-Present Director Research Priority Area Global Health, University of Amsterdam 2001-Present Full Professor Anthropology of Care and Health, University of Amsterdam 2010-2014 Scientific Director, Amsterdam Institute for Social Science Research (AISSR)

Research Awards (selection)

• Principal Investigator Award European Research Council (ERC) Advanced Grant 2012-2018. ChemicalYouth: What chemicals do for youths in their everyday lives (US$ 2.9 million) • Principal Investigator Social Science Ending New HIV infections in Swaziland. AIDS Fonds/Postcode Lottery (US$ 500.000) • Principal Investigator Netherlands Organization for Scientific Research (NWO)/WOTRO (2009-2013). Filling the Gap: Social Institutions and AIDS in Kenya, Tanzania and Zambia. PI (US$ 580.000)

A selection of peer-reviewed articles, special issues, book, chapters • Hardon, A., Taqueban, M., Pell, C., and Narasimhan, M. (2019). Implementing do-it-yourself sexual and reproductive health care for women and girls: insights from ethnographic studies. British Medical Journal. https://doi.org/10.1136/bmj.l1333 • Narasimhan, M., Allotey, P., & Hardon, A. Self-care interventions to advance health and well-being: a conceptual framework to inform normative guidance (Special Issue Introduction, Submitted to British Medical Journal). • Vernooij, E; Mehlo, M; Hardon, A; Reis, R. (2016.) Access for all: contextualizing HIV treatment as prevention in Swaziland. AIDS care, 28(3) 7-13. • Hardon, A. & Idrus, N.I. (2015). Magic Power: changing gender dynamics and sex- enhancement practices among youths in Makassar, Indonesia. Anthropology & Medicine, 22 (1) 49-63. doi: 10.1080/13648470.2015.1010114 • Moyer, E., & Hardon, A. (2014). Special Issue. A disease unlike any other? Why HIV remains exceptional in the age of treatment. Medical Anthropology 33(4): 263-269. • Hardon A., Idrus, N.I. & Hymans, T.D. (2013). Chemical sexualities: the use of pharmaceutical and cosmetic products by youth in South Sulawesi, Indonesia. Reproductive Health Matters 21(41) 214-224. • • Vernooij, E. & A. Hardon (2013). “What mother wouldn't want to save her baby?” HIV testing and counselling practices in a rural Ugandan antenatal clinic. Culture, Health & Sexuality 15(sup4) S553S566. • Hardon, A. & H. Dilger (2011). Special Issue Introduction: Global AIDS medicines in East African health institutions. Medical Anthropology 30(2) 136-157. • Hardon, A. (2005). Confronting the HIV/AIDS epidemic in Sub-Saharan Africa: policy versus practice. International Social Science Journal 57(186) 601-605. • Van der Geest, S., S.R. Whyte & A. Hardon (1996). The anthropology of pharmaceuticals: a biographical approach. Annual Review of Anthropology 25: 153-178. • Hardon, A. (1992). The needs of women versus the interests of family planning personnel, policy makers and researchers: conflicting views on safety and acceptability of contraceptives. Social Science & Medicine 35(6): 753-766. • Hardon, A. ChemicalYouth: Collaborative Experiments in Search of the Good Life (Palgrave 2020). • Hardon, A, M. Tan, & E. Taqueban (Eds.) (2018). Making bodies work: Young people’s everyday body management in urban Mindanao. Quezon City: University of the Philippines • L. Manderson, E. Cartwright and A. Hardon (2016). The Medical Anthropology Handbook. New York, NY : Routledge. (including 5 first author chapters on HIV socialities, sexualities, genes and kinship, markets, and the stresses of everyday life). • Whyte, S.R., S. van der Geest & A. Hardon (2002). Social Lives of Medicines. Cambridge: Cambridge University Press (465 citations as of 08/2018). • Idrus, Nurul Ilmi and Anita Hardon (2015). Chemicals, biocapital and the everyday lives of sex workers and waitresses in South Sulawesi. In Linda Rae Bennett and Sharyn Graham Davies (Eds). Sex and Sexualities in Contemporary Indonesia: Sexual Politics, Health, Diversity and Representations. London: Routledge, pp 129-147

ASH PACHAURI, Ph.D. Phone: +1646.583.0040. Email: [email protected]

Educational Qualifications 2002 Nottingham University Business School UK Yale School of Management (Supervision) USA PhD: Behavioral Science, Management, Technology (Full Scholarship) 1999 Bond University Australia Masters in International Management (GPA 4.0) Vice Chancellor’s and Deans List of Excellence

Additional Professional Training 2004 San Francisco State University USA Health Education: Part I and Part II (Full Scholarship) 2014 Johns Hopkins University – CCP USA Strategic Leadership 2020 Berkeley USA COVID-19 and Public Health Management

Current Work Experience 2016-Ongoing POP (Protect Our Planet) Movement Global Senior Mentor 2016-Ongoing World Sustainable Development Forum (WSDF) Global Treasurer, Secretary, and Member of the Board 2008-Ongoing Center for Human Progress Global Director & CEO

Previous Strategy & Management Experience 2012-2016 Bill & Melinda Gates Foundation (Ananya Program) Global Communications and Knowledge Management 2011-2016 Social Impact USA/India Country Representative 2007-2009 Bill & Melinda Gates Foundation (Avahan Program) Global/India Manager via a consultant satellite office arrangement 2006-2007 International Planned Parenthood Federation (IPPF), South South Asia Asia Regional Office (SARO) Policy Researcher (Consultant) 2005-2007 Program for Appropriate Technology in Health (PATH) India Program Manager (Consultant) 2005-2006 Development Program (UNDP) Asia Program Associate (Consultant) 2002-2004 LLEGO´ USA Curriculum Developer (Consultant) 2002-2003 McKinsey & Company, Inc. USA

1997-1999 McKinsey & Company, Inc. Global

Teaching Experience 2009-2015 International Institute of Health Management Research India Assistant Professor 2011-2015 Collaboration with Johns Hopkins University Global Strategic Leadership Training 1999-2002 University of Nottingham UK Teaching Assistant and Tutor

Publications and awards available on request BIOGRAPHICAL SKETCH POSITION TITLE Associate Professor, NAME Carmen Logie Factor-Inwentash Faculty of Social Work, University of Toronto, Canada EDUCATION/TRAINING INSTITUTION AND LOCATION DEGREE YEAR(s) FIELD OF STUDY University of Toronto, Toronto, Canada B.A. 06/1997 Sociology Eastern Michigan University, MI, USA M.S.W. 06/2003 Social Work University of Toronto, Toronto, Canada Ph.D. 10/2010 Social Work A. Personal Statement: Carmen Logie, PhD is the Canada Research Chair in Global Health Equity with Marginalized Populations, an Associate Professor at the Factor-Inwentash Faculty of Social Work, University of Toronto, an Adjunct Scientist at Women’s College Research Institute, Women’s College Hospital and an Adjunct Professor at the United Nations University Institute for Water, Environment & Health. Her program of research addresses social and structural drivers of sexual and reproductive health with a focus on HIV and STI testing and care with vulnerable young people.

B. Positions (current) 07/2018- Associate Professor, Health and Equity Specialization Factor-Inwentash Faculty of Social Work, University of Toronto, Toronto, ON, Canada 07/2013-18 Assistant Professor, Factor-Inwentash Faculty of Social Work, University of Toronto, Toronto, Canada

C. Publication examples relevant to this meeting: Selected from Logie’s 159 publications (>3600 citations): Examples from Self Care for Sexual and Reproductive Health 1) Logie, C., Okumu, M., Abela, H., Wilson, D., Narasimhan, M. (2020). Sexual and reproductive health mobile apps: Results from a global values and preferences survey to inform WHO normative guidance on sexual and reproductive health and rights. Global Health Action, 13, 1796346 2) Narasimhan, M., Logie, C., Gauntley, A., et al. (2020). Self-Care Interventions for Sexual and Reproductive Health and Rights for Advancing Universal Health Coverage. Sexual & Reproductive Health Matters, 28(2), 1778610. 3) Siegfried, N., Narasimhan, M., Logie, C., et al. (2020). Prioritising gender, equity, and human rights in a GRADE- based framework to inform future research on self care for SRHR. BMJ Global Health, 5:e002128. 4) Logie, C., et al. (2019). The potential for self-care interventions to advance sexual and reproductive health and rights in humanitarian settings. British Medical Journal (BMJ), 365(11083), 1-3. Examples from Working with Refugee and Displaced Populations on Sexual and Reproductive health 1) Logie, C., et al. (2020). Sexually transmitted infections testing practices and diagnosis among urban refugee youth living in informal settlements in Kampala, Uganda: A cross-sectional study. BMJ SRH, 46, 192-199. 2) Logie, C., et al. (2019). Social ecological factors associated with experiencing violence among urban refugee and displaced adolescent girls and young women in informal settlements in Kampala, Uganda. Conflict & Health, 13:60. 3) Logie, C., et al. (2019). Exploring associations between adolescent sexual and reproductive health stigma and HIV testing awareness and uptake among urban refugee and displaced youth in Kampala, Uganda. Sexual & Reproductive Health Matters, 27(3), 86-106.

D. Current Research Support Principal Investigator ($295,246) 2020-21 Canadian Institutes of Health Research COVID-19 Rapid Grant. Project Title: Kukaa Salama (Staying Safe): A Pre-Post Trial of a WhatsApp Social Group for Increasing COVID-19 Prevention Practices with Urban Refugee and Displaced Youth in Kampala, Uganda. Principal Investigator ($761,175) 2020-25 Canadian Institutes of Health Research Project Grant. Project Title: Exploring Pathways to Sexual and Reproductive Health in a Cohort Study with Northern and Indigenous Youth. Principal Investigator ($500,000) 2018- 2023 Canada Research Chair Tier 2. Project Title: Canada Research Chair in Global Health Equity & Social Justice with Marginalized Populations. Principal Investigator ($445,000) 2018- 2021 Canadian Institutes of Health Research Project Grant. Project Title: Tushirikiane (Supporting Each Other): Development, Implementation and Evaluation of Novel HIV Self-Testing Delivery Approaches with Urban Displaced and Refugee Adolescent Girls in Uganda. Principal Investigator ($500,000) 2015-2019 Canadian Foundation for Innovation, John Evans Leaders Fund and Ontario Research Fund. Project Title: Mobile Multi-Media Lab “Stigma and Sexual Health Interventions to Nurture Empowerment (SSHINE Lab)” Daniella Munene

Summary Profile

A health professional with extensive experience in quality management systems, organizational regulatory compliance and health sector policy advocacy.

Through her work Daniella advocates for equitable health for all and seeks to empower people to take charge of their own health.

Daniella holds a Bachelor of Pharmacy degree (University of Nairobi) and is currently pursuing a Master of Science degree in Public Health at Moi University

Experience

Self-injection Ambassador, DMPA-SC Access Collaborative March 2020 to date Global advocate on self-injection best practice engaging donors, normative agencies, government, and implementing partners

Subject Matter Expert - Value Chain, IQVIA November 2019 - April 2020 Provided technical advice on a Kenya Pharmaceutical Industry Diagnostic Study funded by the World Bank

Director, Kenya Healthcare Federation, KHF - the Health Sector Board of Kenya Private Sector Alliance, KEPSA July 2018 to date Provides strategic direction for the federation of private health sector actors in Kenya

Temporary Advisor, World Health Organization March 2018-Jan 2019 Working in the Guideline Development Group, developed evidence- based recommendations for normative guidance on self-care interventions for sexual and reproductive health and rights (SRHR)

CEO, Pharmaceutical Society of Kenya (PSK) Jan 2018 to date Advocacy, policy work, budget, membership drive, stakeholder engagement, team leadership, mentorship and coaching

Other Experience 2007 to 2018 Quality Consultant, Head of Operations, Distribution Manager, and Company Pharmacist at Johnson & Johnson Middle East FZ-LLC, ION Kenya, Limeridge Pharma and Phillips Pharmaceuticals respectively

Tel: +254 (0) 722 333 686 | [email protected] | Twitter: @DaniellaMunene | Skype: dnmunene LinkedIn: Daniella Munene | Facebook: Daniella Munene Personal Data

Name: Elham Ahmed Abdulla Attallah, MD, MSexol

Title: Consultant Family Physician and Clinical Sexologist

Date of Birth: 1972

Mother of three children

Telephone: (+973) 39433770 (Mobile)

Email: [email protected] , [email protected]

Language: Arabic: Mother tongue English: Very good (spoken, written and reading)

Qualification

Masters of Sexology (with distinction), 2009 Curtin University of Technology, Perth, Australia

Training Course in Forensic Sexology (100 Hrs credit), 2008 Curtin University of Technology, Perth, Australia

Postgraduate Diploma in Sexology, 2008 Curtin University of Technology, Perth, Australia

Arab Board Certificate in Family Medicine, 2002 Ministry of Health, Bahrain

Board Certificate in Family Practice Joint Program 2001 accredited by Ministry of Health, Bahrain, and the Irish College of General Practitioners and Royal College of Surgeons in Ireland, Ireland

Doctor of Medicine, MD 1996 College of Medicine & Medical Sciences (CMMS), Arabian Gulf University (AGU) Bahrain

Bachelor of Basic Medical Sciences, B.Med. 1995 Medicine & Medical Sciences (CMMS) Arabian Gulf University (AGU), Bahrain Licensure

1997: Bahrain Medical Licensure Examination, Bahrain

Professional & Clinical Experience

April 2016-Now: Member of WHO Working Group on “Sexual and Reproductive Health and Rights of Women Living with HIV.

Jan 2012-Now: Member of WHO Working Group on the Classification of Sexual Disorders and Sexual Health, for the Revision of ICD-10 Mental and Behavioral Disorders.

Oct 2012-2015: Member of WHO Working Group on “Sexuality counseling guidelines for health care providers”.

Oct 2012-Dec 2013: Doctor-In-Charge Muharraq Health Center, MOH

Feb 2012-Oct 2012: Doctor-In-Charge Al Hoora Health Center, MOH

Jan 2011-Feb 2012: Deputy In-Charge Arad Health Center, MOH Jan 2010-Feb 2012: MCH supervisor, Arad Health Center, MOH

Jan 2010-Now: Clinical Sexologist and In-charge of Sexual Medicine and Marital Counseling clinic, MOH

2010-Now: Senior Lecturer, Royal College of Surgeons in Ireland, Bahrain

Feb 2007-Jan 2008: Clinical Tutor, Family Physician Residency Program (FPRP), MOH, Bahrain

Feb 1998-Feb 2019: Family Physician - MOH, Primary and Public Health Directorate, Bahrain March 2019: Hicare medical centre Research and Publications

Disorders related to sexuality and gender 2016 identity in the ICD-11: revising the ICD-10 classification based on current scientific evidence, best clinical practices, and human rights considerations. World Psychiatry 2016;15:205–221.

Risk Factors for Sexual Dysfunction Among Women and Men: A Consensus 2016 Statement From the Fourth International Consultation on Sexual Medicine 2015. J Sex Med 2016;13:153-167.

Definitions of Sexual Dysfunctions 2016 in Women and Men: A Consensus Statement From the Fourth International Consultation on Sexual Medicine 2015. J Sex Med 2016;13:135 143. Incidence and Prevalence of Sexual 2016 Dysfunction in Women and Men: A Consensus Statement from the Fourth International Consultation on Sexual Medicine 2015. Sex Med 2016;13:144-152.

Proposed declassification of disease categories related to sexual orientation in 2014 the International Statistical Classification of Diseases and related Health Problems (ICD-11). Bulletin of the World Health Organization 2014;92:672-679.

Speaker and Panel Moderator, 21st World 2013 Congress for Sexual Health, Brazil.

Abstract 1-WHO/UNESCO Symposium: Counseling for sexual health concerns - Barriers to presenting sexuality counseling at the health care level”

Abstract 2- “Sexuality around the world - First Specialized Sexology Clinic in Bahrain”. Classification of Sexual Dysfunction in 2012 the Arab World in Relation to ICD-11. The Arab Journal of Psychiatry. (2012) Vol. 23 Supplement, Page (35-41).

Abstract: (Sexual Health Education: a case for the Gulf Region). First global 2013 conference on contraception, reproductive and sexual health. May 22 – 25, 2013 Copenhagen, Denmark

Speaker (Highlights on Sexual Medicine 2012 in the Middle East), Jeddah, Saudi Arabia

Published several articles in «Middle East 2011- Society for Sexual Medicine» Newsletter. now Speaker (Classification of Mental and 2011 Behavioral Disorders in Arab Countries) American University of Beirut Medical Center, Department of Psychiatry, Beirut, Lebanon Speaker (state-of-the-art Lectures) 1st Biennial Meeting of the Middle East 2011 Society for Sexual Medicine, Dubai, UAE

Participant & Poster Presentation, 7th 2010 GCC Primary Health Care Conference, Bahrain

Participant & Poster presentation, 19th Congress of the World Association for 2009 Sexual Health, Goteborg, Sweden

MSc project study. «Physicians› 2009 Attitudes Regarding Sexual Dysfunction Management», Curtin University, Australia Preference of Bahraini Primary Care Attendants Regarding Disclosure of 2001 Serious Illness, Bahrain Activities & Workshops Conducted

2010-Now: Yearly one week course on Human Sexuality conducted for Family Physician Residency Program, MOH, Bahrain

2019: Sexual Dysfunctions Management Workshop, for family physicians

2015: Workshop on Sexual Dysfunctions Management, for Gynecologist and Primary Care Physicians at MOH

2013: Training Workshop on Sexual Health in Primary Care, BMS, Bahrain

2013: Public Workshop targeting Newly married couples, Al Eslah Society Muharraq

2013: Introduction to Sexual Health, Social Workers, MOH, Bahrain

2013: Introduction to Sexual Health, Nurses, College of Health Sciences, University of Bahrain

2012: The first workshop at MOH level delivered to Premarital Couples

2012: Public Lecture (Women›s Sexual Health) Aysha Yateem Social Center 2011: Public Health Promotion Live Television Interview, Bahrain TV

2010: Public Workshop on «My Private Life», Ministry of Social Affairs, Ajman UAE

2010: Public Seminar on Sexuality Targeting Mothers & Teachers of Disabled Children, Ministry of Social Affairs, Ajman UAE

2010: Public Health Promotion Live Television Interview, MBC1 Channel, Dubai UAE

2010: Public Health Promotion on 6th Annual Health Day, Saar Cultural Sports Club, Bahrain

2010: CME Accredited Lecture on Sexual History Taking, Arad Health Center, Bahrain

2010: Public Seminar on Sexual Health & Marital Relationship, Dessange Health Club, Bahrain

2010: CME Accredited Lecture on Sexual Health, American Mission Hospital, Bahrain 2010: Training Workshop on Sexual Health in Primary Care, BMS, Bahrain

2009: Successful Aging for Women Conference, King Abdulaziz University, Jeddah, KSA

Membership of Societies

Member, The World Association for Sexual Health (WAS)

Member, Middle East Society for Sexual Medicine (MESSM)

Member and one of the founding group of Network of Arab Scholars On Sexuality & Sexual Health (NASSS) Prof Elizabeth Anne Bukusi Chief Research Officer, Center for Microbiology Research Kenya Medical Research Institute Associate Research Professor, University of Washington, Honorary Lecturer, Dept. of ObGyn, Aga Khan DEGREE Completion Date INSTITUTION AND LOCATION FIELD OF STUDY MM/YYYY University of Nairobi, Kenya MBChB 12/1987 Medicine University of Nairobi, Kenya M.MED 12/1995 Obstetrics and Gynecology University of Washington, Seattle, WA MPH 12/2000 Epidemiology University of Washington, Seattle, WA PhD 08/2006 Epidemiology University of Cape Town, South Africa PGD 06/2011 Research Ethics Centre for Bioethics and Culture (SIUT) MBE 2013 Bioethics

A. Personal Statement My primary research focuses on sexually transmitted infections, reproductive health, and HIV prevention, care, and treatment. In 1995, in collaboration with colleagues at the University of Washington, we established the Research Care and Treatment Program at the Centre for Microbiology Research within the Kenya Medical Research Institute (KEMRI). In addition to conducting research, the program aims to enhance local capacity to conduct socio-behavioral and biomedical research and provide HIV care through training and infrastructure development. In addition to my substantial experience conducting research in Kenya, providing HIV care, and mentoring and training different cadres of health care and research personnel, I have an interest in ethics and the development of systems and structures for regulating research in the institute and the country. I supervised the restructuring of the research regulation system at KEMRI, revising the research guidelines, improving investigator education, and instituting a mechanism for monitoring approved research projects and currently am the PI and director for a training grant which is building capacity for a broad based bioethics training for Kenya and an EDCTP grant building capacity for oversight of regulation for clinical trials in Kenya. I served on the data and safety monitoring boards for the MIRA (diaphragm), CAPRISA 004 trial, IPM 027 studies. I was the second co-chair of the Kenya HIV and AIDS Research Coordinating Mechanism of the National AIDS Control Council (NACC), and currently serve on the Kenya National HIV Prevention Task Force. I served on the World Health Organization’s (WHO’s) Department of Reproductive Health Scientific Technical Advisory Group from 2008 to 2014 and currently serve is the departments HRP Alliance (capacity building) chair. I was the inaugural chair KEMRI’s Sexual, Reproductive, and Child Health Program Committee from inception to 2014, and co-chaired the HIV Prevention Trials Network’s (HPTN’s) Women at Risk Committee to 2014. I currently serve as the first non-South African to be appointed to the South African Medical Research Council Board of management. Honors 2017 King Holmes endowed Professor in STD and AIDS, University of Washington, Departments of Medicine and Global Health Positions and Employment 1995-present Honorary Lecturer and Senior Registrar, Department of Obstetrics and Gynecology, University of Nairobi, Kenya 2010-present Department of Obstetrics and Gynecology, Aga Khan University, Nairobi, Kenya 2011-2016 Deputy Director, Research and Training, KEMRI, Kenya 2016-present Research Professor, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 2016-present Research Professor, Department of Global Health, University of Washington, Seattle, WA 2016-present Chief Research Officer, KEMRI, Kenya

Contribution to Science My early work on the effect of pelvic inflammatory disease among HIV infected women contributed to recommendations of treatment of mild PID among women with HIV as outpatient oral medication. As a follow up my subsequent work on Bacterial vaginosis and the association male partners and recurrence of BV contributed to better understanding of socioeconomic factors affecting female genital hygiene. The expansion of HIV care within the region in Kenya with the highest HIV prevalence and the platform for research in various aspects of HIV care/integration and socioeconomic concerns have led to improving health outcomes for those living with HV in the region and contributing to scientific output. I have contributed to the advancement of research regulation at the Kenya Medical Research institute including the reorganization of the structure of the institutional review boards including a book to improve research review for Sub Saharan Africa.

GINA SUZANNE OGILVIE

Current roles

Professor, School of Population and Public Health, Faculty of Medicine, University of British Columbia Canada Research Chair, Global Control of HPV related diseases and Cancer, Vancouver, Canada Associate Director, Women’s Health Research Institute, BC Women’s Hospital, Vancouver, Canada Senior Scientist, BC Centre for Disease Control, Vancouver, Canada Affiliated Scientist, BC Cancer, Vancouver, Canada

Previous (relevant) roles

Medical Director, BC Centre for Disease Control, Vancouver, Canada

Education University or Institution Degree Subject Area Dates University of North Carolina, Doctor of Public Health (DrPH) Health Leadership 2009-2012 Chapel Hill University of British Columbia Master of Science Clinical Epidemiology 1998-2001 McMaster University Fellowship Population Health and 1994-1995 Primary Care McMaster University CCFP Family Medicine 1992-1994 McMaster University MD Medicine 1989-1992 Queen’s University BSc(H) First Class Honours Biology 1985-1989

Professional Qualifications Fellow, College of Family Physicians of Canada Member, American Society of Colposcopy and Cervical Pathology Member, College of Family Physicians of Canada Member, Society of Obstetricians and Gynecologists of Canada

Selected Funding

Granting Agency Subject COMP $ Year Principal (Total) Investigator Ministry of Health, Elimination of Cervical NC 10,000,000 2019 Gina Ogilvie Government of Cancer Canada NIH Addressing emerging health C 1,700,000 2018 Gina Ogilvie system priorities in cervical (USD) cancer prevention: determining optimal strategies for HPV based screening and triage CIHR Increasing HPV vaccine C 199,650 2018 Gina Ogilvie uptake in the school based Julie Bettinger program in rural and remote BC CIHR Bridging the cancer divide: C 199,027 2018 Sheona Leveraging community Mitchell-Foster strengths and optimizing Mark Gilbert technology use to improve Gina Ogilvie screening for Indigenous women in northern BC Bill and Melinda HPV One Dose Consortium C 4,000,000 2017 Scott Gates Foundation LaMontagne

GINA OGILVIE: Technical Advisory Group, WHO BC Cancer BC Cancer Foundation C 151,625 2017- Dirk van Foundation Strategic Priority Fund 2019 Niekerk Award Gina Ogilvie Mark Gilbert Merck Co. Long term memory NC 279,300 2016- Simon Dobson responses to HPV vaccine 2019 following 2 vs 3 doses of Q- HPV CIHR (PHSI) Optimizing the detection C 395,000 2016- Gina Ogilvie and management of cervical 2019 Mel Krajden cancer screening Dirk van Niekerk

CIHR Quadrivalent Vaccine C 135,000 2016- Gina Ogilvie Evalution Study 18 CFI: John Evans Global control of HPV C 154000 2015- Gina Ogilvie Leadership Fund related cancer 2018 CIHR Integrated global control of C 2,714,492 2015- Gina Ogilvie Foundation Grant HPV related disease and 2022 cancer CIHR Long-term immunogenicity C 1, 521,546 2014- Deborah Money and clinical efficacy of the 2018 quadrivalent HPV vaccine in HIV positive girls and women BCCDC Foundation Quadrivalent vaccine C 285,000 2012- Gina Ogilvie for Population evaluation study (QUEST) 2013 Health Research MSFHR Quadrivalent vaccine C 2,200,000 2012- Gina Ogilvie evaluation study (QUEST) 2024 CIHR Diagnostic characteristics of C 98,652 2011- Mark Gilbert self collected specimens for 2013 Gina Ogilvie sexually transmitted infections: A systematic review CIHR Advances in Screening and C 24,591 2011- Gina Ogilvie Prevention in Reproductive 2012 Josaphat Cancers (ASPIRE) – Byamugisha Dissemination Activities Jan Christilaw Deborah Money Ian Roe Musa Sekikubo Malcolm Steinberg Aptima APTIMA HPV Study; Adjunct NC 629,400 2010- Andrew to the HPV FOCAL Study 2015 Coldman CIHR Advancing Public Health C 25,000 2010 - Trevor Services Research in Canada: 2011 Hancock, Developing a Pan-Canadian Marjorie Agenda MacDonald, Gilles Paradis CIHR A Study of an HPV VLP C 1,444,728 2008- Deborah Money Vaccine in a Cohort of HIV 2013 Positive Girls and Women Ministry of Health A controlled trial to Assess the NC 800,000 2007- Simon Dobson Immunogenicity of a Proposed 2010 Pediatric Dosing Schedule of HPV vaccine

GINA OGILVIE: Technical Advisory Group, WHO PHAC Factors predicting parental NC 25,000 2007- Gina Ogilvie attitudes to HPV Vaccination 2008 CIHR A Randomized Controlled C 6,268,935 2007- Andy Coldman Evaluation of HPV Testing 2014 Gina Ogilvie for Cervical Cancer Screening

Invited presentations (selected)

An update on innovations in HPV vaccine dosing and novel approaches for cervical cancer screening. World Health Organization Reproductive Health Research team. Geneva, Switzerland. September 2015

HPV vaccine programming in Canada. Strategic Advisory Group of Experts, Pan American health Organization/World Health Organization. Washington, DC. February 2017

Screening methods for cervical cancer: Recent Advances and remaining challenges. International Papillomavirus Conference. PATH/CDC Session. Capetown, South Africa. March 2017

HPV vaccine programs for the Caribbean countries. Strategic Advisory Group of Experts, Pan American Health Organization/World Health Organization. Miami, Florida. May 2017 (invited)

Improving uptake of the HPV vaccine. Asia Pacific Economic Council. Hanoi, Vietnam. August 2017 (invited)

Optimizing prevention of cervical cancer through secondary prevention. Program for appropriate technology in health. September 2017 (global webinar)

Update on the HPV FOCAL trial. 32nd International Papillomavirus Conference. Sydney, Australia. October 2018

Optimizing use of HPV screening (invited). Eurogin, Monaco, December 2019

International Conference Participation (selected)

Reviewer, International Papillomavirus Conference, Cape Town, Republic of South Africa. March 2017

Session Chair, Preparing for implementation of HPV screening. International Papillomavirus Conference, Cape Town, Republic of South Africa. March 2017

Session Chair. Reduced dosing of the HPV vaccine. International Papillomavirus Conference, Cape Town, Republic of South Africa. March 2017

Member, Organizing Committee. European Organization for Gynecologic Cancer (Eurogin). Amsterdam, The Netherlands. October 2017

Session Chair. Implementation of the HPV vaccine. European Organization for Gynecologic Cancer (Eurogin). Amsterdam, The Netherlands. October 2017 (invited)

Member, Organizing Committee, STI & HIV World Congress 2019, Vancouver BC.

Member, Organizing Committee, Women Deliver. Vancouver BC, June 2019

Member, Organizing Committee, European Organization for Gynecologic Cancer, Barcelona, Spain. March 2020

Member, Organizing Committee, 34th International Papillomavirus Conference, Toronto, Canada. October 2021

GINA OGILVIE: Technical Advisory Group, WHO Centers for Disease Control and Prevention, Improving Data for Decision-Making in Global Cervical Cancer Programs (IDCCP). Atlanta, USA. September 2014- 2018

Asia Pacific Economic Cooperation Cervical Cancer Expert Group. National Institutes of Health. Washington, DC. September 2016- 2019

International Committee Membership (selected) Asia Pacific Economic Cooperation: Advisory member. Roadmap to promote sustainable Economic Advancement for Women through Cervical Cancer Prevention and Control. September 2016-presnet. Lima, Peru

Program for Appropriate Technology in Health, Single Dose HPV vaccine Consortium, November 2017 - present

International Advisory Roles (selected) Canadian Partnership Against Cancer, Advisory Committee, Elimination of Cervical Cancer, April 2019

World Health Organization, WHO Guideline Development Group for user-initiated interventions for sexual and reproductive health and rights (SRHR) January 2019

World Health Organization. WHO Guideline Development Group for user-initiated interventions for sexual and reproductive health and rights (SRHR) April 2018 Chateau de Penthes, Geneva, Switzerland (invited)

World Health Organization. Brocher Foundation. Ethical, legal, human rights and social implications of user- initiated interventions in sexual and reproductive health. March 12-14, 2018 Geneva Switzerland (invited)

Government of Nunavut. HPV vaccine program design and implementation. Iqualuit, Nunavut. February 2017

Pan American Health Organization. HPV vaccine program design and implementation. Washington, DC. January 2017

Canadian Cancer Society and Public Health Agency of Canada. Burden of HPV related cancer in Canada. The Canadian Cancer Society and Statistics Canada. April 2016

Expert Technical Consultation, Development of survey modules for population-based surveillance of cervical cancer screening and treatment. World Health Organization and Centers for Disease Control and Atlanta. Seattle, Washington, August 2014

HPV Simulation Model Expert panel member, Joint Initiative in Vaccine Economics, University of Michigan and Centers for Disease Control and Prevention. Ann Arbor, Michigan. June 2014

World Health Organization, Geneva, Switzerland. Alternate dosing schedules and evaluation for HPV vaccine November 2012

AWARDS AND DISTINCTIONS (Selected)

• Member, Her Excellency Julie Payette’s Governor General’s Delegation, Republic of Rwanda, April 2019

• YWCA Woman of Distinction, Research and the Sciences, Vancouver, 2018

• Options for Sexual Health Champion, Options for Sexual Health. Vancouver May 2018

• President’s Award, Medical Staff Association of Children’s and Women’s Health Centre. Vancouver April 201

• Recipient, Provincial Health Officer’s Award for Excellence in Public Health, British Columbia, 2015

GINA OGILVIE: Technical Advisory Group, WHO

Selected publications (from >160 publications)

Ogilvie GS, Krajden ML, Maginley J, Isaac-Renton J, Hislop G, Elwood-Martin R, Sherlock C, Taylor DL, and Rekart ML. Feasibility of self-collection of specimens for human Papillomavirus testing in hard-to- reach women. Can Med Assoc J 2007 177: 480-483

Gunther OP, Ogilvie GS, Naus M, Young E, Patrick DM, Dobson SR, Duval B, Noel PA, Marra F, Miller D, Brunham RC, Pourbohloul B. Protecting the next generation: What is the role for the duration of HPV vaccine immunity? Journal of Infectious Diseases. 2008;197:1653-61.

Ogilvie GS, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, McIvor M, Ehlen T, Dobson S, Money D, Patrick DM, Naus M. A Population-Based Evaluation of a Publicly Funded, School-based HPV Vaccine Program in British Columbia, Canada: Parental Factors Associated with HPV Vaccine Receipt. Public Library of Science Medicine. 2010 May 4;7(5):e1000270.

Mitchell S, Ogilvie GS, Steinberg M, Sekikubo M, Biryabarema C, Money DM. Assessing women's willingness to collect their own cervical samples for HPV testing as part of the ASPIRE cervical cancer screening project in Uganda. International Journal of Gynecology and Obstetrics. 2011 Aug; 114(2):111-5. (IF 1.9; Citations 7) doi: 10.1016/j.ijgo.2011.01.028

Ogilvie GS, Cook D, Taylor DL, Rank C, Kan L, Yu A, Mei W, van Niekerk D, Coldman A, Krajden M. Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada. Vaccine 2012 10.1016/j.vaccine.2012.09.085 doi: 10.1016/j.vaccine.2012.09.085

Simon RM Dobson, Shelly McNeil, Marc Dionne, Meena Dawar, Gina Ogilvie, Mel Krajden, Chantal Sauvageau David W Scheifele, Tobias R Kollmann, Scott A Halperin, Joanne M Langley, Julie A Bettinger, Joel Singer, Deborah Money, Dianne Miller, Monika Naus, Fawziah Marra, Eric Young. A randomized controlled trial to assess immunogenicity of a two-dose quadrivalent human papillomavirus vaccine schedule in Canadian younger adolescents: Results to Month 36. Journal of the American Medical Association 2013; 309(17):1793-1802

Ogilvie GS, Mitchell S, Sekikubo M, Biryabarema C, Byamugisha J, Jeronimo J, Krajden M, van Niekerk D, Miller D, Christilaw J, Steinberg M, Money DM. Results of a community-based cervical cancer screening pilot project using human papillomavirus self-sampling in Kampala, Uganda. International Journal of Gynaecology and Obstetrics 2013; Aug;122(2):118-123 doi: 10.1016/j.ijgo.2013.03.019

Ogilvie GS, Smith L, van Niekerk DJ, Khurshed F, Krajden M, Saraiya M, Goel V, Rimer B, Greene S, Hobbs S, Coldman AJ, Franco EL. Women’s intentions to receive cervical cancer screening with primary human papillomavirus testing. International Journal of cancer 2013;133:2934-2943 doi: 10.1002/ijc.28324

Smith, LW; Khurshed F; van Niekerk DJ; Krajden M; Greene SB; Hobbs S; Coldman AJ; Franco EL; Ogilvie GS. Women’s intentions to self-collect samples for human papillomavirus testing in cervical cancer screening. BMC Public Health 2014, 14:1060 doi:10.1186/1471-2458-14-1060

Erin Moses, Heather Pedersen, Sheona Mitchell, Musa Sekikubo, David Mwesigwa, Joel Singer, Christine Biryabarema, Josaphat Byamugisha, Deborah Money, Gina Ogilvie. Uptake of community- based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: Preliminary results of a randomized controlled trial. Tropical Medicine and International Health doi:10.1111/tmi/12549

Sheona M. Mitchell, Heather Pedersen, Musa Sekikubo, Christine Biryabarema, Josaphat J. K. Byamugisha, David Mwesigwa, Malcolm Steinberg, Deborah M. Money, Gina S. Ogilvie. Strategies for community education prior to clinical trial recruitment for a cervical cancer screening intervention in Uganda. Frontiers in Oncology 2016 Apr 13;6:90. doi: 10.3389/fonc.2016.00090

GINA OGILVIE: Technical Advisory Group, WHO

Narasimhan M, Vermund SH, Ogilvie G. Biomedical technologies for the prevention of sexually transmitted infections and HIV for adolescent girls and young women. Trans R Soc Trop Med Hyg. 2016;110(9):499-501. https://doi.org/10.1093/trstmh/trw062

Mitchell SM, Pedersen HN, Eng Stime E, Sekikubo M, Moses E, Mwesigwa D, Biryabarema C, Christilaw J, Byamugisha JK, Money DM, Ogilvie GS. Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity. BMC Womens Health. 2017;17(1):4. doi: 10.1186/s12905-016-0360-0

Mezei A, Armstrong H, Pedersen H, Campos N, Mitchell S, Sekikubo M, Byamugisha J, Kim JJ, Bryan S, Ogilvie GS. Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: a systematic review. International Journal of Cancer. 2017 Aug 1;141(3):437-446. doi: 10.1002/ijc.30695.

Gina Ogilvie, Chantal Sauvageau, Marc Dionne, Shelly McNeil, Mel Krajden, Deborah Money, Simon Dobson. Immunogenicity of 2 vs 3 doses of the quadrivalent HPV vaccine in 9-13 year old girls after 60 months. Journal of the American Medical Association JAMA. 2017 Apr 25;317(16):1687-1688. doi: 10.1001/jama.2017.1840

Manjulaa Narasimhana, Heather Pedersen, Gina Ogilvie and Sten H. Vermund. The case for integrated human papillomavirus vaccine and HIV prevention with broader sexual and reproductive health and rights services for adolescent girls and young women. Trans R Soc Trop Med Hyg 2017; 111: 141–143. doi:10.1093/trstmh/trx032

Mezei AK, Pedersen HN, Sy S, Regan C, Mitchell-Foster SM, Byamugisha J, Sekikubo M, Armstrong H, Rawat A, Singer J, Ogilvie GS, Kim JJ, Campos NG. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial. BMJ Open. 2018 Jun 12;8(6):e020484. doi: 10.1136/bmjopen-2017-020484.

Gina Suzanne Ogilvie, Dirk van Niekerk, Mel Krajden, LaurieW. Smith, Darrel Cook, Lovedeep Gondara, Kathy Ceballos, David Quinlan, Marette Lee, Ruth Elwood Martin, Laura Gentile, Stuart Peacock, Gavin C. E. Stuart, Eduardo L. Franco, Andrew J. Coldman. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months. The HPV FOCAL Randomized Clinical Trial. JAMA. 2018;320(1):43-52. doi:10.1001/jama.2018.7464

Talia Malagon, Shalini Kulasignam, Marie-Helene Mayrand, Gina Ogilvie, Leah Smith, Celine Bouchard, Walter Gotlieb, Eduardo L. Franco. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modeling study. Lancet Oncology 2018. http://dx.doi.org/10.106/S1470-2045(18)30536-9

Moses E, Pedersen HN, Wagner EC, Sekikubo M, Money DM, Ogilvie GS, Mitchell-Foster SM. Understanding Men's Perceptions of Human Papillomavirus and Cervical Cancer Screening in Kampala, Uganda. J Glob Oncol. 2018 Sep;(4):1-9. doi: 10.1200/JGO.17.00106.

Ogilvie GS, Phan F, Pedersen HN, Dobson SR, Naus M, Saewyc EM. Population-level sexual behaviours in adolescent girls before and after introduction of the human papillomavirus vaccine (2003-2013). CMAJ. 2018 Oct 15;190(41):E1221-E1226. doi: 10.1503/cmaj.180628.

Malagón T, Kulasingam S, Mayrand MH, Ogilvie G, Smith L, Bouchard C, Gotlieb W, Franco EL. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study. Lancet Oncol. 2018 Dec;19(12):1569-1578. doi: 10.1016/S1470- 2045(18)30536-9.

GINA OGILVIE: Technical Advisory Group, WHO Curriculum Vitae

SYED HUSSAIN JAFRI

Address 167 B, PCSIR II, Lahore, Pakistan Contact +92-300-4580584 Email: [email protected]

Affiliation Board Member World Patients Alliance (WPA) Sept 2019 – to date The WPA is a global patients alliance that provides the platform to empower and raise the patients’ voice for the provision and access to safe, quality and affordable healthcare.

Vice Chair Advisory Group, WHO Patients for Patients Safety Program Sept 2014 – to date

Current Job Deputy Project Director Punjab Thalassaemia Prevention Project Oct 2015 – to date Provincial Focal Person Patients Safety & Quality, Punjab May 2019 – to date

Maternal Health Related Experience Project Coordinator Punjab Safe Motherhood Initiative Project Dec 2004 – Sept 2010 Headed the Project Implementation and Monitoring Unit (PIMU), which provided Emergency Obstetrics care at the door steps of the people in District Sheikhupura.

Team Leader Research Cell on Reproductive Health July 2007 – Aug 2010 Headed the Research Cell on Reproductive Health, the first research cell developed on Reproductive Health by the Government trough Punjab Safe Motherhood Initiative project. The unit held several national and international researches.

Coordinator Jahandad Society for Community Development (JSCD) July 2002 – Nov 2004 Worked as the Coordinator of JSCD and managed projects on Advocacy & Social mobilization on Women Health.

Project Coordinator Maa’n Bachao Mohim Sept 2000 – June 2002 Headed the Fatima Jinnah Medical College Lahore (FJMC) & UNICEF collaborative Pilot Project on Provision of Emergency Obstetric Care Services to selected government health facilities of Lahore & Sheikhupura.

Maternal Health Related Publications (Last Two Years Only )

1 WHO Consolidated Guideline on Self-Care Interventions for Health External Review group Member Sexual and Reproductive Health and Rights 2019 2 Should oral contraceptive pills be available without a prescription? A BMJ Glob Health. June 2019 systematic review of over-the-counter and pharmacy access 3 Decision-making on antenatal screening results: A comparative Q- Submitted at Health Expectations for method study of women from two Chinese cities ( publication) 4 Autonomous decision-making for antenatal screening in Pakistan: European J. Hum Genetics June views held by women, men and health professionals in a low- 2019 middle income country. 5 Interpretations of autonomous decision-making in antenatal genetic European J. Hum Genetics April screening among women in China, Hong Kong and Pakistan. 2018

Education PhD 2015 Topic: Attitudes toward prenatal diagnosis and termination of pregnancy in Pakistan School of Medicine, Uni. of Leeds, UK

Dr. Jayalakshmi Shreedhar Ph: +91 9840777649 Email: [email protected] And [email protected] No:9, Nungambakkam High Road, Chennai 600 034 ......

Jaya is a medical doctor based in Chennai, India. A former special correspondent covering health and medicine at Frontline magazine, she presently teaches the Health Journalism elective course at the Asian College of Journalism, Chennai, https://www.asianmedia.org/acj/programme/elective-courses/ that includes a focus on health and human rights through the lens of HIV and SRH. She also serves as Senior Technical Expert, Accountability and Media Engagement, REACH http://www.reachtbnetwork.org/ with REACH (Resource Group for Education and Awareness in Community Health) in country level projects related to TB and TB/HIV and NCDs that includes projects on patient-centerd care and self-care. Jaya also works as Health and COVID19 Media Mentor for Asia, with Internews https://internews.org/updates/pandemic-media-mentors-offer-deep-range-skills- support-partners-grappling-covid-19

As a trainer, she has helped build capacity among journalists from developing and developed countries in reporting on AIDS, TB, health and human rights. She has about 20 years of working experience with NGOs, governmental agencies and international agencies in various projects involving HIV, SRHR, TB and Diabetes related policy development, program planning, documentation, report/proposal writing and advocacy. She has served as a consultant to UNAIDS (Geneva and India), WHO-SEARO (India)UNDP, UNICEF, USAID’s AIDS Prevention and Control project (APAC) in Tamil Nadu and India’s National AIDS Control Organization, besides Indian state governments.

Jonathan Hopkins South Africa address: 45 Roosevelt Road, Cape Town, 7708 ● Email: [email protected] ………………………………………………………………………………………………………. Profile A highly motivated development professional with Senior Management experience. Specialise in international development related to homelessness, gender equality, HIV, and sexual and reproductive health and rights (SRHR), capacity building, strategy development, programme management and research. ………………………………………………………………………………………………………. Employment History U-turn, Cape Town, South Africa Chief Operations Officer Dec 2016 – present Acting Chief Executive Officer Oct 2019 – Mar 2020  Leadership: Responsible for the organisations programmes and services which deliver 30,000+ touch points to 1000+ street people per year. Also responsible for the retail social enterprise, which includes a clothing distribution centre and six charity shops.  Business development: Preparing the organisation to set up a social franchise to franchise its successful rehabilitative model.  Strategic partnership building: A member of Executive Committee of the Cape Town Street People’s Forum and Cape Town representative on the South African National Network on Street Homelessness.  Monitoring and Evaluation: Oversee research as well as the monitoring and evaluation systems for the organisation, strengthening where required, for example improving the capturing of baseline and outcome data.

Independent Consultant (part time) Sept 2016 - present Contracts have included:  Developing a gender equality strategy and implementation plan for IPPF (IPPF, 2017)  Research coordinator for a needs assessment on young men and adolescent boys SRHR in Eastern and Southern Africa (UNFPA, 2018-2019)  Conducting a review of WHO RHR departments work on SRHR and HIV Linkages (WHO, 2016)  Developing a series of evidence briefs and guidelines for health workers and manager for transitioning to the Namibian Primary Healthcare integrated service delivery model (UNFPA, 2017-18)  Developing research tools to conduct a national assessment on the current status of SRHR and HIV integration in Togo, Guinea, Cameroon and Malawi, and writing the final report (IPPF ARO, 2017-18)  Developing innovative tools and resources on SRHR and HIV Linkages including the SRHR and HIV Linkages Index and Toolkit (WHO & UNFPA, 2016-17)  Rapporteur for “WHO technical consultation on hormonal contraception and HIV” (WHO, 2019)

International Planned Parenthood Federation, London, UK Senior Technical Advisor: HIV Mar 2012 – Aug 2016  Technical leadership: Lead IPPF work on SRH and HIV integration and male engagement in SRH and HIV.  Strategic partnership building: Built and maintained partnerships with donors, UN agencies, civil society organizations and other international, regional and national stakeholders in the SRH and HIV arena. Co-chaired the Inter-Agency Working Group on SRH and HIV Linkages (www.srhhivlinkages.org) and chaired IPPF Men and Boys Task Team and was a board member of MenEngage Alliance.  Building capacity: Supported IPPF Member Associations to strengthen their HIV-related services and working with men and adolescent boys as clients, partners and agents of change.  Fundraising and programme management: Designed, mobilised resources for and managed concurrent SRH and HIV projects including responsibility for donor reporting, budget management and M&E.  Monitoring and Evaluation: Focal point for HIV-related data analysis and utilization; lead an international process to develop a compendium of SRH and HIV linkages indicators and tools; and co- lead the development of an SRH and HIV Linkages Index (http://index.srhhivlinkages.org).  Innovation: Founded the IPPF Men and Boys Task Team to reinvigorate IPPFs work with men and boys for gender equality. Succeeded in securing US$750,000 of internal funds (through the IPPF Innovation Fund) to support IPPF Member Associations to strengthen work in this area.  Strategy development: Member of IPPF 2016-2022 high level Strategic Framework Development Group.  People Management: Recruited and supervised project staff, consultants and contractors.

United Nations Population Fund, Mbabane, Swaziland Technical Advisor: SRH and HIV Linkages (6-month contract) Sept 2011 – Feb 2012  Managed the start-up of a Ministry of Health led USD 2 million project to improve the integration of sexual and reproductive health and HIV services at a national level.  Set up M&E systems for the project including designing and implementing a baseline assessment.  Designed and managing an innovative catalytic project – in collaboration with the Ministry of Health – to strengthen the prevention of mother-to-child transmission of HIV.  Member of Senior Management Team and represented UNFPA at the national level  Created new partnerships and stronger working relationships with key stakeholders.

International Planned Parenthood Federation, London, UK HIV Officer: Youth Jan 2010 – Sept 2011 HIV Officer: Research and Technical Support Oct 2007 – Dec 2009  Managed concurrent projects and programmes from a variety of donors (approx. $1m per year).  Strengthened partnerships, fundraised and represented IPPF on national and international bodies.  Provided technical support and built capacity of IPPF country partners, staff and youth advocates on HIV and SRH. Led the IPPF work on young people living with HIV.  Developed technical tools, best practice guidelines and training guides relating to HIV, sexual and reproductive health and rights and young people.  Recruited and line managed a project assistant as well as many consultants and other contractors.

Other work experience:  Primary School Teacher, Canon Andrea Mwaka School, Dodoma, Tanzania Jan 2004 – June 2006  Information services clerk, Bournemouth and Poole College Sept 2003 – Jan 2004  Lay Assistant, St Aldates Church Aug 2002 – Aug 2003 ………………………………………………………………………………………………………. Education University of York, United Kingdom MA in Conflict Governance and Development (Distinction) Oct 2006 – Sept 2007 Dissertation: ‘The role of the church in supporting sustainable community development in rural Tanzania’ Oxford University, United Kingdom BA (Honours) Politics, Philosophy and Economics (2:1) Sept 1999 – June 2002 ………………………………………………………………………………………………………. Professional Development Practical Statistics in Medical Research, University College London, 2015 Management Training: Moving into management, The Centre for Strategy and Communication, 2012 Managing Rural Development, Short course (MA level), CeDEP, SOAS, 2010 Water Resource Management, Short course (MA level), CeDEP, SOAS, 2010 Introduction to Monitoring and Evaluation, INTRAC, 2009 ………………………………………………………………………………………………………. Voluntary Work Chair of Board of Trustees, All Saints Church Peckham, London, UK Apr 2012 – May 2014 ………………………………………………………………………………………………………. Selected Relevant Publications  Sonke Gender Justice & MenEngage Africa (2017) 10 reasons to focus on improving the HIV response for men: meeting the fast-track commitments to end AIDS by 2030 [author]  Hopkins, J., Collins, L. (2017) ‘How linked are national HIV and SRHR strategies? A review of SRHR and HIV strategies in 60 countries’ Health Policy and Planning Vol 32 (Suppl. 4)  Warren, C., Hopkins, J., Narasimhan, M., Collins, L., Askew, I., Mayhew, S. (2017) ‘Health systems and the SDGs: lessons from a joint HIV and Sexual and Reproductive Health and Rights response.’ Health Policy and Planning Vol 32 (Suppl. 4)  UNFPA & IPPF (2017) The global SRH service package for men and adolescent boys [co-author]  Warren, C., Mayhew, S., Hopkins, J. (2017) ‘The current status of research on the integration of sexual and reproductive health and HIV services’ Studies in Family Planning Vol 48(2).  IPPF (2014) The men and boys collection: Stories of gender justice and sexual and reproductive health and rights [co-author]  Lusti-Narasimhan, M., Collins, L., Hopkins, J. (2014) ‘Lessons learnt from SRH and HIV Linkages for Multipurpose Prevention Technology (MPT) service delivery’ BJOG 2014; 121 (Suppl. 5): 87–91  IPPF (2013) Adolescents Count Today: Improving the quality of life of adolescents living with and affected by HIV in Kenya [lead author]  Government of Rwanda, IPPF, UNAIDS, UNFPA, WHO (2013) Gateways to Integration: A case study from Rwanda [co-author]  IATT on EMTCT, IPPF, UNFPA, UNICEF, WHO (2013) Eliminating mother-to-child transmission of HIV and keeping their mothers alive: A job aid for healthcare workers [co-author] ………………………………………………………………………………………………………. Languages Languages: English (Native) KiSwahili (moderate) ……………………………………………………………………………………………………. References Available on request Curriculum Vitae

Kaosar Afsana Professor, James P Grant Sname: chool of Public Health, BRAC University, Dhaka, Bangladesh Email: [email protected]; and [email protected] Phone: +8801711404572

Personal Statement I have nearly three decades in public health especially working in reproductive, maternal, neonatal and child and adolescent health and nutrition and early childhood development; community health and primary health care; health system strengthening; humanitarian setting; gender; and equity. I aspire to do my work to influence for a decent world with dignity and respect for the people living a disadvantageous life.

Education • PhD in Public Health, Edith Cowan University, Western Australia, 2003 • MPH in International Health, Harvard School of Pubic Health, Massachusetts, USA, 1997 • MBBS, Dhaka Medical College, Dhaka University, Bangladesh, 1983 Award • GSK-Save the Children Health Innovation Award for Manoshi 2014 • The Woman of Distinction Award 2011 by UN NGO Committee, New York 2011 • D.K. Agencies India’s award for the best Australian doctoral thesis on an Asian subject 2005 • Asian Studies Association of Australia's Presidents' Prize for the best thesis on Asian topic 2004 Publications (citation of few relevant published papers and books) 1. Afsana K. Heard and Hard Reality of Maternal Health: Are We Oversimplifying the Challenges in Bangladesh? In Emma J. Flatt, Vani S, Murali, Silvia Tieri (eds). Voices on South Asia: Interdisciplinary perspectives on Women's Status, Challenges and Futures. Singapore: World Scientific, 2020. 2. Jolly SP, Chowdhury, T, Rahman M, Alam A, Afsana K. Prevention of social exclusion and role of antenatal care by BRAC community health workers in improving safe motherhood and neonatal care in urban slums of Bangladesh. July 2020. PLoS ONE 15(7):e0235340. 3. Cross S, Gon G, Morrison E, Afsana K, Ali SM, Manjang T, Manneh L, Rahman A, Saxena D, Vora K, Graham WJ. (2019) An invisible workforce: the neglected role of cleaners in patient safety on maternity units, Global Health Action, 12:1, 1480085, DOI: 4. Bhutta ZA, Bang A, Afsana K, Gyawali B, Mirzazada S, Jayatissa R. Rethinking community based strategies to tackle health inequities in South Asia. BMJ 2018; 363:k4884. 5. Nambiar D, Razzak, J, Afsana K, Adams AM, Hasan A, Mohan D, Patel V. Mental Illness and Injuries: Emerging Health Challenges of Urbanization in South Asia. The BMJ. 2017; 357: J1126 6. Kruk ME, Kujawski S, Moyer CA, Adanu RM, Afsana K, Cohen J, Glassman A, Labrique A, Reddy KS, Yamey G. Next generation maternal health: external shocks and health system innovations. Lancet Sept 15, 2016. 7. Afsana K, Rashid SF, Islam KF, Hashim P. Health Care in Urban Slums of Bangladesh. Taking Services at the Doorsteps of the Poor? In Syed Masud Ahmed et al (eds) Urban Health Scenario. Looking Beyond. Bangladesh Health Watch 2014, BRAC University: Dhaka, 2015. 8. Campbell OMR, Benova L, Gon G, Afsana K, Cumming O. Getting the basics right – the role of water, sanitation and hygiene in maternal and reproductive health; a conceptual framework. PLOS Medicine, 2014. 9. Rounaq J, Afsana K. Sustaining Progress toward Comprehensive Reproductive Health Services in Bangladesh. Global Public Health Dec 2014. 10. Afsana K, Evans J. Crisis of health workforce in Bangladesh: a non-government organization’s experience in deploying community health workers in primary health care, Perspectives in Public Health, September 2014 134 (5): 253-254. 11. Afsana K, Haque MR, Sobhan S, Shahin SA. BRAC’s experience in scaling-up MNP in Bangladesh. Asia Pac J Clin Nutr 2014;23(3):377-384. 12. Afsana K, Wahid SS. Health care for poor people in the urban slums of Bangladesh. The Lancet 2013, Dec 21;382(9910):2049-51 13. Afsana K. Empowering Community for Improving Maternal and Neonatal Care: Evidence from BRAC’s Interventions in Bangladesh. In Julia Hussein, A McCaw-Binns and R Webber (Eds.). Maternal and perinatal mortality in developing countries, Oxford: CABI, 2012. 14. Afsana K. Rohde J, Decline in Neonatal mortality in large poor populations. The Lancet. 2011, Jun 25;377(9784):2178-9 15. Moran A, Wahed T, Afsana K. Oxytocin to augment labour during home births: an exploratory study in the urban slums of Dhaka, Bangladesh. BJOG 2010;117:1608–1615. 16. Afsana, K. Scaling up of BRAC’s Maternal, Neonatal and Child Health Interventions in Bangladesh, In R Cash, AMR Chowdhury, GB Smith and F Ahmed (Eds.). From One to Many: Scaling health Programs in Low Income Countries, Dhaka: The University Press Limited, 2010. 17. Afsana K, Rashid SF. Constructions of Birth. In H. Selin and P.K. Stone (Eds.). Childbirth across Cultures: Ideas of pregnancy, Childbirth and post-partum period, New York: Springer, 2009. 18. Afsana K, Rashid SF. Voices and Accountability. The State Of Health in Bangladesh 2006. Challenges of Achieving Equity in Health. Bangladesh Health Watch, BRAC University: Dhaka, 2007. 19. Afsana, K, Rashid, SF, Chowdhury, AMR, Theobald, S. Promoting maternal health: Gender equity in Bangladesh, British Journal of Midwifery, 15 (11): November, 2007 20. Afsana, K. Disciplining Birth. Power, Knowledge and Childbirth Practices in Bangladesh, The University Press Limited, Bangladesh, 2005. 21. Afsana K. The tremendous costs of seeking hospital obstetric care in Bangladesh, Reprod Health Matters, Vol 12, No. 24, pp 1-11, November, 2004 22. Afsana K, Rashid SF. A women-centred analysis of birthing care in a rural health centre in Bangladesh, Access to Quality Gender-Sensitive Health Services. Women-Centred Action Research, ARROW, Malaysia, 2003 23. Afsana K, Rashid SF. The Challenges of meeting rural women’s needs in delivery care, Reprod Health Matters, Vol. 9, No. 18, pp 1-15, November 2001 24. Afsana K, Rashid SF. Discoursing Birthing Care: Experiences from BRAC, Bangladesh, The University Press Limited, Bangladesh, 2000 Professional Association • Scientific Committee, UN Food System Summit 2021, United Nations, New York • Strategic Committee, Ahimsa Renaissance Think Tank, Ahimsha Fund, Lyon • Advisory Committee, Social Innovations on Health, London School of Hygiene and Tropical Medicine, London • External Advisory Committee, International Health and Tropical Medicine, Oxford University, Oxford • Board of Directors, Global alliance for Improved Nutrition, Geneva, Switzerland • Advisory Committee, Simprints, Cambridge • External Advisory Group on Integration of Wasting Treatment into Routine Health Systems, Results for Development, Washington DC • Academic, Research and Training, The Partnership of the Maternal, Neonatal and Chilc Health, Geneva

Kevin Moody Reguliersgracht 49-3, 1017 LL Amsterdam, The Netherlands / +31 6 81913800 / [email protected]

Experience

Managing Director, Kevin Moody Consulting 11/2013 - present • Strategic policy, communications, programme management and technical research and writing services. Examples of services provided in the areas of HIV/AIDS, SRHR, health programmes and regulatory affairs: Desk research and report writing. Programme and academic course evaluations. Clinical and communications documents for professionals and patients. Interim executive management services. Workshop design, delivery and report-writing. Advocacy plans. Member: WHO Guideline Development Group on Self-Care Interventions for SRHR in 2019

International Coordinator / CEO, Global Network of People Living with HIV 03/2006 – 10/2013 • Development of patient-derived, evidence-based data generation on key topics including stigma, criminalisation and SRHR to drive strategic communications, advocacy and fundraising. Implementation of extensive innovative consultative processes to inform policy development, communications, advocacy and programming.

Technical Officer, HIV Department, World Health Organization, Geneva 03/2004 – 03/2006 Co-Director (Campaigns), Health Action International, Amsterdam 03/2002 – 03/2003 Co-ordinator, Access to Medicines Campaign, Médecins sans Frontières 02/2000 – 02/2002

Education

Bachelor of Science in Pharmacy (BScPhm), University of Toronto, 1986 Master of Business Administration (MBA), University of British Columbia, 1991 Doctor of Education (EdD), Nova Southeastern University, 2000 Masters-level Graduate Certificate, EU Regulatory Affairs, Danube University Krems, 2017

Publications and Presentations (examples)

• Siegfried N, Narasimhan M, Logie C, Thomas R, Ferguson L, Moody K, Remme M. Prioritising gender, equity and human rights in a GRADE-based framework to inform future research for sexual and reproductive health and rights self-care. BMJ Glob Health. 2020; 5(3): e002128. • Moody K, “Self care won’t address structural barriers to health, but it can help meet the needs of men who have sex with men.” The BMJ Opinion. 1 April 2019. • “In search of the 4th 90: Exploring and defining what quality of life means for communities and strategising how we get there.”, Workshop developer, speaker, moderator and report writer, International AIDS Conference, Amsterdam, 25 July 2018. • Rispel, L.C., Metcalf, C.A., Moody, K., Cloete, A., Caswell, G., “Sexual relations and childbearing decisions of HIV-discordant couples: An exploratory study in South Africa and Tanzania.”, Reproductive Health Matters, Vol 19, No. 37, pp 184-193, 2011. • “Options for Prevention, Treatment and Care”, Participatory Methods for a People-Centred Health System, Bagamoyo, Tanzania, 27 February 2008. • “Sexual and Reproductive Rights of PLHIV: Threats and Opportunities”, International Conference on Actions to Strengthen Linkages Between SRH and HIV Mumbai, 5 February 2007 • Bell, E., Mthembu, P., O’Sullivan, S., Moody, K., “Sexual and Reproductive Health Services and HIV Testing: Perspectives and Experiences of Women and Men Living with HIV and AIDS”, Reproductive Health Matters, Vol. 15, No. 29, pp. 113-135, May 2007.

Community Leadership

Trustee, Frontline AIDS (formerly the International HIV/AIDS Alliance), Brighton, 2013-present Trustee, AIDS Fonds/Stop AIDS Now!/STD-AIDS Netherlands, Amsterdam, 2008-2015 Member, Supervisory Board, HIV Justice Network, Amsterdam, 2020-present

Languages

English: native speaker; Dutch: fluent; German: conversational; French: conversational CURRICULUM VITAE LAURA ELAINE FERGUSON OCTOBER 2020

PERSONAL INFORMATION: 2001 North Soto Street, SSB 318H, MC 9239, Los Angeles, CA 90089-9239, USA Email: [email protected]

EDUCATION AND PROFESSIONAL APPOINTMENTS EDUCATION: 1996-2000 MA (Awarded), French and Spanish, Univeristy of Cambridge, New Hall, Cambridge, UK 2003-2005 MS, Population and International Health, Harvard University, School of Public Health, Boston, MA 2008-2011 PhD, Global Public Health, London School of Hygiene and Tropical Medicine, London, UK 2014 Certificate with Distinction, International Human Rights Law: Prospects and Challenges (On-line Course), Duke University, Durham, NC

ACADEMIC APPOINTMENTS: 2016-present Assistant Professor of Spatial Sciences Institute, Dana and David Dornsife College Preventive Medicine and of Letters, Arts, and Sciences, University of Southern Spatial Sciences California, Los Angeles, CA 2015-present Assistant Professor of Department of Preventive Medicine, Keck School of Medicine Preventive Medicine University of Southern California, Los Angeles, CA 2012-2015 Assistant Professor of Department of Preventive Medicine, Keck School of Medicine Research University of Southern California, Los Angeles, CA 2009-2014 Research Associate University of Nairobi Institute of Tropical and Infectious Diseases, Nairobi, Kenya 2007-2008 Adjunct Professor Suffolk University, Boston, MA 2005-2011 Visiting Scientist Program on International Health and Human Rights, Harvard School of Public Health, Boston, MA

ADMINISTRATIVE APPOINTMENTS: Year Description Institution, City, State, Country 2018-present Director of Research Institute on Inequalities in Global Health, University of Southern California, CA 2018-present Director Program on Global Health and Human Rights, Institute for Global Health, University of Southern California, CA 2016-2018 Associate Director Program on Global Health and Human Rights, Institute for Global Health, University of Southern California, CA SELECT ADVISORY BOARDS: Year Position, Board Organization 2016-present Expert Working Group, Indicator Development on UNAIDS Discrimination Experienced in Healthcare Settings. 2018-2019 Guideline Development Group, Self-Care Interventions for World Health Organization Sexual and Reproductive Health and Rights. 2015-2017 Expert Advisory Group, Strengthening Quality of Care in World Health Organization Contraceptive Programmes through Development of a Human Rights Based Quality Assessment Tool. 2013 Steering Committee, Contested Domains: Harvard Center for Sexual and Reproductive Health and Rights of People Living Population and Developent with HIV, Faculty Group on Reproductive Health and Rights. Studies, Harvard University

SELECT JOURNAL ARTICLES AVAILABLE AT: https://profiles.sc-ctsi.org/laura.ferguson#toc-id2 Curriculum Vitae Leonashia Leigh Ann van der Merwe

Education

Current: Registered for Master of Public Health (MPH), University of South Africa (2020). (Dissertation submitted for examination)

Work Experience: • Founder & Director of Social, Health and Empowerment Feminist Collective of Transgender Women of Africa • Consultant on sexual and gender minority populations

Skills: • Content development: involved in developing content for numerous organisations relating to sexual and gender minorities; • My strength lies in public health approaches and methodologies as it relates to minority populations; • Research: Vast research experience including being a co-principal investigator for the first Bio-Behavioural Survey to estimate HIV prevalence among transgender women in three South African cities, a mixed method study to determine the cost of being a transgender woman in South Africa, and a research endeavour on violence against transgender people in Southern Africa. • Writing: I have been first and co-author on research papers in the field of HIV/Aids as it relates to key populations. I have also contributed to community media as well as mainstream media in journalistic writing on my subject field;

• Poteat, T., Malik, M., van der Merwe, L. L. A., Cloete, A., Adams, D., Nonyane, B. A. S. and Wirtz, A. L. (2020) ‘PrEP awareness and engagement among transgender women in South Africa : a cross-sectional , mixed methods study’, The Lancet HIV, 3018(20), pp. 1–10. • L. Leigh Ann Van der Merwe, Cheryl Nikodem & Deborah Ewing (2020) The socio-economic determinants of health for transgender women in South Africa: Findings from a mixed-methods study, Agenda, DOI: 10.1080/10130950.2019.1706985 Complete list on request

• Community mobilisation: I have a long career of working with communities at the grassroots level. I founded an NPO working to the attainment of health and human rights for transgender people; • Grant writing: I would describe myself as a fairly good grants writer. I started the NPO from 0$ to over $500,000; • Advocacy and policy shifts: I am one of the pioneers of transgender activism in South Africa dating back to 2005; after which we had made significant policy changes for our community in South Africa; • Leadership & Governance: I am a board member of various organisations where I contribute to leadership and governance discourses in the field of non-profit, feminism and human rights. In this capacity, I also mentor many young transgender women who are new to the movement. I am a board member of the Sisonke Sex Worker Movement, the Innovative Response Globally to Transgender Women & HIV, a working group member of the Technical Working Group on LGBTI & HIV in South Africa. • Grantmaking: I currently advise the ViiV Health Positive Action Group as a review committee member to decide on which groups to fund. • Strategic management and planning: I am involved with numerous organisations in different capacities where I contribute to the organisational strategy, including grant and broader financial management.

A detailed list of references can be made available on request.

[Document Title] 16 Duke Crescent, Buffalo Flats, East London, South Africa Email: [email protected] Mobile number: 0738110789 Lisa Miyako Noguchi, PhD, CNM

EDUCATION AND CERTIFICATION 2011-2014 PhD, Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA 1996-1997 MSN, Nursing, University of Pennsylvania, Philadelphia, USA 1993-1995 BSN cum laude, Nursing, University of Pennsylvania, Philadelphia, USA 1989-1993 BA magna cum laude, Biomedical Anthropology, University of Pennsylvania, Philadelphia, USA 1997-present Certified Nurse-Midwife, American Midwifery Certification Board, Linthicum, USA

APPOINTMENTS AND POSITIONS 2018-2020 Director, Maternal Newborn Health, Jhpiego, Baltimore, USA 2016-2019 MCSP Zika Response Team Lead, Jhpiego, Washington, DC, USA 2014-2016 MCSP Maternal Health Advisor, Jhpiego, Washington, DC, USA 2014-2020 Associate, Department of Epidemiology, Bloomberg School of Public Health, Baltimore, USA 2006-2020 Multiple roles, Research Operations, MTN, Univ. of Pittsburgh Medical Center, Pittsburgh, USA 2004-2006 Nurse-Midwife/Research Clinician, University of Pittsburgh Medical Center, Pittsburgh, USA 1999-2004 Nurse-Midwife, St. Luke’s Women’s Center, St. Luke’s Healthcare Center, San Francisco, USA 1998-1999 Nurse-Midwife, Milford Obstetrics and Gynecology, P.C., Hopedale, USA 1998-1999 Registered Nurse (all OB/GYN units), Brigham and Women’s Hospital, Boston, USA 1998 Lecturer/Clinical Instructor, Holy Family Hospital School of Nursing, Phalombe, Malawi

GLOBAL TECHNICAL WORKING GROUPS AND EXPERT COMMITTEES AlignMNH/IMNHC Program Committee 2020-present IDSOG Scientific Program Committee 2019-2020 Safe in Pregnancy Advisory Group 2019-2020 WHO Perinatal Executive Guideline Steering Group 2017-2019, 2019-2021 WHO Technical Advisory Group on Global Preterm Birth Rates 2017-2018 Roll Back Malaria – Malaria in Pregnancy Working Group 2015-2019 WHO Antenatal Care Guidelines Guideline Development Group 2015-2016

HONORS 2014 Young Investigator Award, Conference on Retroviruses & Opportunistic Infections 2012-2013 U.S. Public Health Service Training Grant 2011-2013 Mary B. Meyer Scholar in Maternal Child Health

SELECTED PUBLICATIONS Noguchi L et al. Effect of group versus individual antenatal care on uptake of intermittent prophylactic treatment of malaria in pregnancy and related malaria outcomes in Nigeria and Kenya. Malar J (2020). 19(1):51. Noguchi LM, Simelela P. How should we listen to ECHO? The Lancet (2019). 394(10195): 275-276. Noguchi LM et al. Pharmacokinetics of Dapivirine Transfer into Blood Plasma, Breast Milk, and Cervicovaginal Fluid of Lactating Women Using the Dapivirine Vaginal Ring. AAC (2019). 63(3): e01930-18. Noguchi LM et al. Detectable tenofovir levels in breastfeeding infants of mothers exposed to topical tenofovir. AAC (2016). pii: AAC.00645-16. Noguchi LM et al. Risk of HIV-1acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study. Lancet HIV (2015). Jul 1;2(7): e279-e287. Marrazzo JM et al. Oral and topical tenofovir-based preexposure prophylaxis for HIV infection among African women. NEJM (2015). 372: 509-518.

OTHER Current Research Support: Bill & Melinda Gates Foundation, US NIH UM1AI068633 Reviewer for The Lancet, WHO IMPC Managing Complications in Pregnancy and Childbirth, JAIDS Maternal Newborn Health Technical Support Experience: Africa, Asia, Latin America and the Caribbean

09OCT2020 Michelle Remme, PhD Address UNU-IIGH Building, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Kuala Lumpur, Malaysia Telephone +60 11 51570 846 E-mail [email protected]

Languages English – Mother tongue Spanish – Proficient French – Bilingual Swahili – Beginner Dutch – Fluent Career summary • Health Economist working in global health research, technical assistance, and policy development for the past 13 years, both at the international and country level (in sub-Saharan Africa and South-East Asia) • Specific technical areas of expertise in the economics and financing of sexual and reproductive health programmes; health systems financing, including results-based financing; innovative co-financing models for multi-sectoral action on the social determinants of health; incentives for community health volunteers; public- private partnerships; aid effectiveness and the economics of violence against women and girls programming. • Internationally recognised expert in the financing of interventions to address the social determinants of health, particularly for HIV (with applications to health system strengthening, tuberculosis, nutrition and intimate partner violence); regularly invited to join global technical working groups, contribute to global strategy documents, review grant applications and articles for high impact peer-reviewed public health journals • Experience in diverse work environments: UN (UNU, FAO, WHO, UNDP, World Bank), academia (London School of Hygiene and Tropical Medicine), bilateral (Dutch Ministry of Foreign Affairs), and private consulting

Professional Experience

May 2018 – Present Research Fellow – United Nations University – International Institute for Global Health (UNU-IIGH), Kuala Lumpur, Malaysia

2011 – 2018 Assistant Professor in Health Economics – London School of Hygiene & Tropical Medicine, London, United Kingdom

2015 – 2018 Scientific Collaborator – Ifakara Health Institute, Dar es Salaam, Tanzania

2005 – 2016 Consultant in Health Economics and Financing – World Health Organization, World Bank, United Nations Development Programme, Overseas Development Institute, Cordaid, ETC Crystal, South African Medical Research Council

2007 – 2010 HIV/AIDS, Gender and Food Security Officer – Food and Agriculture Organization, Lilongwe, Malawi

2005 – 2006 Junior Policy Officer HIV/AIDS and Health – Dutch Ministry of Foreign Affairs, The Hague, The Netherlands

Education

2013 – 2018 PhD in Health Economics London School of Hygiene and Tropical Medicine (LSHTM), London, United Kingdom 2001 – 2005 Master of Science in International Economics and Finance cum laude Tilburg University, the Netherlands

Selected Publications Remme M, Martinez-Alvarez M, Vassall A. Cost-Effectiveness Thresholds in Global Health: Taking a Multisectoral Perspective. Value in Health. 2017 Apr;20(4): 699-704. Remme M, Siapka M, Sterck O, Ncube M, Watts C, Vassall A. Financing the HIV response in sub-Saharan Africa from domestic sources: moving beyond a normative approach. Social Science & Medicine. 2016 Nov;169:66-76. Remme M, Watts C, Heise L, Vassall A. Secondary schooling might be as good an HIV investment as male circumcision. The Lancet Global Health. 2015 Oct;3(10):e591. Remme M, Siapka M, Vassall A, Heise L, Jacobi J, Ahumada C, Gay J, Watts C. The cost and cost-effectiveness of gender-responsive interventions for HIV: a systematic review. Journal of the International AIDS Society. 2014 Nov 4;17:19228. Siapka M, Remme M, Obure CD, Maier CB, Dehne KL, Vassall A. Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countries. Bulletin of the World Health Organization. 2014 Jul 1;92(7):499-511 Remme M, Vassall A, Lutz B, Luna J, Watts C. Financing structural interventions: going beyond HIV-only value for money assessments. AIDS. 2014 Jan 28;28(3):425-34. Vassall A, Remme M, Watts C, Hallett T, Siapka M, Vickerman P, Terris-Prestholt F, Haacker M, Heise L, Haines A, Atun R, Piot P. Financing essential HIV services: a new economic agenda. PLoS Medicine. 2013 Dec;10(12):e1001567. Vassall A, Remme M. Financing tuberculosis control: promising trends and remaining challenges. The Lancet Global Health. 2013 Aug;1(2):e62-3. Vassall, A., Remme, M & Piot, P. (2012) World response to Aids needs new vigour. Financial Times. Nov, 2012. Vassall A, Remme M, Watts C. Social Policy. Chapter in RethinkHIV: Smarter Ways to Invest in Ending HIV in Sub-Saharan Africa. Edited by Bjørn Lomborg Copenhagen Business School. Cambridge, Cambridge University Press. 2012. Remme M, Vassall A, Lutz B, Watts C. Paying girls to stay in school: a good return on HIV investment? The Lancet. 2012 Jun 9;379(9832) Remme M, Mukonoweshuro F, Stloukal L. Agricultural policy responses to HIV and AIDS: Lessons from East and Southern Africa. Chapter in A. Niehof, G. Rugalema & S. Gillespie (eds.) AIDS and Rural Livelihoods: Dynamics and Diversity in sub-Saharan Africa. London: Earthscan, Chapter 12. 2010. Nagoli, J., Holvoet, K., Remme, M. HIV and AIDS Vulnerability in Fishing Communities in Mangochi District, Malawi. African Journal for AIDS Research. 2010. 9(1): 71-80. Remme, M., Elhassan, E., Njoumeni, Z., Tushune, K., Nwaorgu, O., Ekpo, U., Zubairu, M., Giwa, H., Oshiname, F & Turinde, A. (2008) External Monetary Incentive Policies for Community Volunteers, Analysis Report of a Multi- country Study. Ouagadougou: World Health Organization/ African Programme for Onchocerciasis Control.

Sheryl van der Poel Geneva, Switzerland

Current positions (from 2017)

-Retired, World Health Organization -Independent Consultant; Infertility, Reproductive Medicine, Reproductive Health -Honorary Member, and Education Committee Member of the International Federation of Fertility Societies (IFFS) -Affiliate Member of the International Federation of Gynecology and Obstetrics (FIGO) Reproductive and Developmental Environmental Health Committee, Liaison for the Education Sub-Committee -Consultant and Advisor for the American Society of Reproductive Medicine (ASRM), President-elect for the ASRM Access to Care Special Interest Group -Global Scientific Advisor for Carrot Fertility (start-up providing methods for global access to fertility care, no payments or renumerations, cumulative <5000 USD, to date)

Past Positions

World Health Organization Scientist/Medical Officer, WHO-HQ, Sexual & Reproductive Health/Human Reproduction Programme Geneva, Switzerland Secretary of the Panel, HRP Research Project Review Panel (RP2) Secretary of the Group, HRP, Scientific and Ethics Review Group (SERG) Focal person, Infertility, Fertility Care, Prepregnancy (preconception) Care, Ethics, Environmental health and reproduction Asia Acting Chair, Ethics Review Board for Cord Blood Bank, Public Health, Singapore Assistant Director, Research Studies, Singapore Health Services Research, SGH, Singapore Director, Laboratory, KKK Women and Children’s Hospital, Cord Blood Bank, Singapore Chief Scientific Officer, CordLife, Singapore (merger with Cytogenetics, spin-off of NASA tech and Harvard start-up) Director, Montessori Educational Foundation School, Manila, the Philippines Asst. Professor/ Head of Laboratory for Oncology, Clinical Department and Medical School, National University of Singapore/ National University Hospital, NUMI, Singapore (BRCA1, cadherin, catenins, breast and ovarian cancer) Germany Research clinical fellow, Tuebingen, Germany United States of America Clinical researcher, Oncology, University of Chicago (identified and named a stem cell gene, MLL at 11q; and a tumour suppressor gene at 9p) Laboratory assistant/ Biomedical researcher: University of Illinois, Champaign-Urbana, IL / Northwestern University, Evanston IL (botany/ biochemistry/ DNA sequencing/ hematological disorders)

Editorships

Deputy Editor, Global Reproductive Health Guest Editor, Infertility Surveillance, IFFS Reports Ad hoc Reviewer: Human Reproduction Open, PlosMed, BMJ Global Health, BMJ, Health Research Policy and Systems, Reprod Biomed Online, Fertility & Sterility, IJGO. Past member of the Editorial Board, WHO Bulletin

Publications

84 publications basic research & systematic reviews, as well as several book chapters, abstracts linked to oral presentations 60+ presentations at international and regional conferences, including educational fertility care programmes in LMICs

Academic Qualifications, Certifications and Training • Sub-specialty in Reproduction/ Reproductive Genetics, Stem Cell Differentiation & Development Fellowships: Universtitatsklinikum/ MaxPlanc Institute, University of Tuebingen, Tuebingen, Germany. • Ph.D/MD Molecular Genetics, Cellular Biology and Human Development/Oncology University of Chicago • B.Sc. Biology/Science Education//M.S./Genetics Molecular Biology Laboratory Training University of Illinois (Champaign-Urbana, IL), Northwestern University (Evanston, IL) • Certificate Courses in Ethics and Human Rights; Health and Human Rights Harvard University (Boston, MA)

S van der Poel, 2020 CV for GDG Self-care

P.O. BOX C970. THE HUB. MANZINI. ESWATINI TEL: +26876025092 EMAIL: [email protected], [email protected] (WORK)

Name: Zelda Nompumelelo NHLABATSI Nationality: Swazi Countries worked: Eswatini, Zambia, Sudan, Kenya, Nigeria, Senegal, Tanzania, Zanzibar and Ethiopia

Education Jan 2011 to Certificate in Health Management, Foundation for Professional Development, December 2011 South Africa September 1997 to MA, Educational Studies, University of York, United Kingdom October 1998 August 1984 to May Bachelor of Science, University of Eswatini, Eswatini 1988 August 1986 to May Diploma in Education, University of Eswatini, Eswatini 1988

Employment record: 2012-Present Executive Director: Provide Strategic Leadership and management for the Family Life Association of organisation Eswatini (FLAS) 2008-June 2012 Programs Director: to guide and provide technical guidance to FLAS Family Life Association of programs Eswatini September 2002 – Aug 2008 Municipal AIDS Programme Manager: Working with the local AMICAALL 2007 Consultant. Developed a comprehensive HIV & AIDS response framework UNESCO for the Education sector through research and stakeholder consultations.

June 2003 - 2007 Consultant: Formulation of Niger Delta Integrated Development Programme UNDP to address the challenges of the Niger Delta region. Orientation of NGOs & Government ministries on CCE-CC in 6 sub-Saharan Africa countries. Development of CCE –CC UNDP Handbook 1999 – August 2002 Head of Research unit: Undertake research studies for schools health SHAPE program. 1999-2000 Training Officer. Provided education and training to students and teachers SHAPE on sexual reproductive health. January 1989 – 1995 Head of Math & Science Department and a Science teacher Mentor. T GOVERNMENT

RESEARCH EXPERIENCE 1999: Qualitative & Quantitative Research Methods as part fulfilment for Thesis of the Master of Arts in Educational Studies on Learning science through contexts: helping pupils make sense of everyday situations. 2001: Lead Researcher. Choose Life – Eswatini. Perceptions of young people on sexual and reproductive health, including HIV 2000: Lead Researcher: SHAPE: A Situational Analysis of Sexual and Reproductive Health Services in Schools in Eswatini. 2008 – 2012: INTEGRA Initiative Programme Research – Assessing the Benefits of Integrating SRH & HIV services. 2016 – 2018: Randomised Control Trial Site Principal Investigator. The Evidence for Contraceptive options and HIV Outcomes (ECHO) Study 2018 – 2022: Co-Investigator: HIV Prevention Trials Network (HPTN) 084 References 1. Ms Lungile Dlamini. Chief Executive Officer, Manzini City Council, P.O. Box 5585, Mbabane. Eswatini. Email: [email protected]. +268 7608 5050

2. Dr. Simon Zwane. Principal Secretary. Ministry of Health. Government of Eswatini. Tel. +268 7606 3221. Email: [email protected]

Page 1 of 1 Hera Ali 36 Higher Reedley Road, Brierfield, Lancashire, BB9 5HA 07973840149 [email protected] / [email protected] Education

Sept 2019 IPSF Trainer (Delivered over 80 hours of trainings) International Pharmaceutical Students’ Federation (IPSF) Sept 2018 Training Development Camp Graduate IPSF 2014-2018 MPharm with Honours (First Class) University of Central Lancashire (UCLan), Preston, Lancashire

Work Experience

December 2019 – Current Rotational Clinical Pharmacist, Fairfield General Hospital, Bury • Clinical monitoring and review of patients’ medication, to ensure effective risk management in the use of medicines including interpretation of laboratory tests and therapeutic drug monitoring. • Individualise patient’s drug therapy according to their disease state • Provide expert advice to medical staff, nurses and patients, regarding need for dose adjustments, therapy changes and therapeutic drug monitoring.

August 2018 – August 2019 Pre-Registration Pharmacist, Boots, Preston, Lancashire • Assisted in in the operations and dispensing of prescriptions and the supply of pharmaceutical products including controlled drugs and appliances ensuring safety and clinical appropriateness. • Responded to symptoms and recommended appropriate over the counter medication. • Counselled and advised patients appropriately under supervision. • Developed good management, leadership and communication skills to prepare for future role as a qualified pharmacist.

Volunteering

February 2020 – Current International Pharmaceutical Students’ Federation Chairperson of Public Health • Focal point of IPSF to the World Health Organisation (WHO) • Lead a team of 30 individuals, to coordinate public health campaigns on a global level, monitor and evaluate the implementation and impact of the public health projects. • Advocate for major public health issues, on a global level with external partners, advocating for the inclusion of youth, pharmacy students who the future healthcare professionals.

October 2019 – February 2020 International Pharmaceutical Students’ Federation Public Health Advocacy Coordinator • Serve as the second focal point of the Federation for the WHO which includes taking responsibility for managing the participation of IPSF members at WHO-related events. • Led the advocacy initiatives of the federation from a global level, on areas such as AMR and Vaccine Hesitancy

October 2018 – October 2019 International Pharmaceutical Students’ Federation Public Health Committee Member • Working on and developing current and future public health campaigns, working in collaboration with the WHO, International Committee of the Red Cross (ICRC), to facilitate public health campaigns on a local level.

PO-CHIN LI [email protected] +886-932-081777 704 Tainan City, Taiwan

Education Research

School of Medicine Evaluation of hand-writing performance National Cheng Kung University (NCKU) of preterm children at school-age, 2015 09/2014 – present Awarded by 2015 Summer Research Programme of College of Medicine, NCKU National Tainan First Senior High School Linguistic Class Preparedness for emergency in mass 09/2010 – 06/2014 gathering, 2016 A project for “On Doctoring,” course of School of Experience Medicine, NCKU President Advocates International Federation of Medical Students’ Association (IFMSA) 2019 Advisory Board Meeting of Western 10/2020 – 09/2021 Pacific Association of Medical Education Singapore, Singapore President Student Representative Federation of Medical Students in Taiwan (FMS-Taiwan) 2018 69th World Health Organisation 09/2018 – 08/2019 Regional Committee for Western Pacific Manila, Philippines Speaker of Students’ Council Head of IFMSA Delegation NCKU Students’ Association - Statement on agenda point “Legal Structure 09/2017 – 06/2018 for Health in SDGs in each member state,”

Language 2017 World Health Assembly (WHA) Geneva, Switzerland Spokesperson of Taiwan healthcare students’ Mandarin delegation English 2016 Global Conference on One Health Japanese Kitakyushu, Japan French Student Representative

Professor Mukesh Kapila, CBE

Dr Kapila has extensive experience in global and public health, international development, humanitarian affairs, conflict and security issues, human rights and diplomacy, and social entrepreneurship, with substantive leadership roles in government, United Nations system and multilateral agencies, International Red Cross and Red Crescent, civil society, and academia. He is also an author and public and media speaker.

His work has taken him to some 120 countries in all continents. Originally schooled in India and England, Dr Kapila graduated in medicine from the University of Oxford and received postgraduate qualifications in public health from the London School of Hygiene and Tropical Medicine.

Since 2012, Dr Kapila has been the Professor (now Emeritus) of Global Health & Humanitarian Affairs at the University of Manchester, UK where he also founded and chaired the Manchester Global Foundation. Since 2020, he is also Senior Adviser to the Parliamentary Assembly for the Mediterranean, the principal forum for 29 national parliaments of the -Mediterranean region to deliberate on the creation of the best political, social, economic and cultural environment and conditions for fellow citizens of the member states.

After an initial clinical career (1980-1984) in hospitals and general practice in Cambridge, and then in public health (1984-1990) including initiating and leading the first National UK HIV/AIDS Programme, Dr Kapila joined the UK Government’s Foreign and Commonwealth Office in 1990 at the Overseas Development Administration where he oversaw British aid health programmes in Asia and Pacific, Latin America and Caribbean, followed by a spell based in Central and Southern Africa. Subsequently, he went on, at the Department for International Development (1994-2002), to found and head a large new government department for conflict and humanitarian affairs covering crisis and emergency situations due to wars and disasters worldwide. In that role, he was responsible for several global initiatives to reform and strengthen the international multilateral humanitarian and human rights systems, and represented the UK in numerous fora at the , UN General Assembly, and on the boards of UN agencies.

Dr Kapila was seconded by the UK Government to the United Nations in 2002-03 initially as Special Adviser to the UN Special Representative of the Secretary General in Afghanistan and then to the UN High Commissioner for Human Rights in Geneva. He then became the United Nations’ Resident and Humanitarian Co-ordinator for Sudan (2003-04) leading what was at the time, the UN’s biggest operation in the world. in 2004, he arrived at the headquarters of the World Health Organization in Geneva as Director for Emergency Response handling major operations such as for the Indian Ocean Tsunami.

In 2006, he joined the International Federation of Red Cross and Red Crescent Societies, the world’s largest humanitarian and development network serving in different roles such as Special Representative of the Secretary General, Director of Policy and Planning, and finally as Undersecretary General where he oversaw several transformations and strategic interventions to scale-up programming.

Dr Kapila has also served in many policy advisory roles, conducted strategic reviews and formulated new programmes with several other international agencies such as the World Bank, UNAIDS, International Labour Organization, UN OCHA and ISDR, as well as served on the Boards of the UN Institute for Training and Research, the Geneva Centre for the

Democratic Control of Armed Forces, and the International Peace Academy. He was an early member of the UN Disaster Assessment and Coordination System. He was closely involved in the development of the original Millennium Development Goals (MDGs), and their successor, the current Sustainable Development Goals (SDGs).

He returned to the United Nations in 2015-2016 to serve as Special Adviser for the first-ever World Humanitarian Summit in Istanbul, and then in 2018-2019 to found and direct the innovative Defeat-NCD Partnership at the UN.

Additionally, he has been active in several civil society groups including chairing the Council of Minority Rights Group International, and chairing the Board of Nonviolent Peaceforce that was nominated for the 2016 . He has initiated new initiatives on sexual and gender based violence and, as Special Representative of the Aegis Trust, on the prevention of genocide and other crimes against humanity. These came out of his personal experiences in witnessing, at first hand, the genocidal atrocities in Rwanda, Srebrenica, and Darfur.

He has also been a Senior Member of Hughes Hall College at Cambridge University, professor at the Geneva School of Diplomacy and International Relations, visiting professor at the International Center for Humanitarian Affairs, Nairobi, and Associate Fellow at the Geneva Centre for Security Policy.

Dr Kapila has received several awards for his public service. In 2003 he was bestowed as a Commander of the Order of the British Empire by Her Majesty Queen Elizabeth II. In 2007 he received the Dr Jean Mayer Global Citizenship Award of the Institute for Global Leadership for (as stated): “moral courage, personal integrity, and passion…dedicated to solving the most pressing problems facing the world”. In 2013, he was given the “I Witness” Award for human rights protection and, in 2014, the California State Legislature passed its Special Resolution 395 for recognising (as stated) “a lifetime of achievements and meritorious service to humanity”.

Dr Kapila has been a public motivational and keynote speaker at numerous events including at TedX, and delivered in Nairobi in 2013, the memorial lecture in honour of winning environmental activist .

He has written extensively and served on editorial boards of several publications such as Global Governance and the International Journal of Humanitarian Studies. His memoir “Against a Tide of Evil” was nominated for the 2013 Best Non-Fiction Book award by the Crime Writers Association and is being filmed. His latest book (2019) is entitled “No Stranger to Kindness”. www.mukeshkapila.org Twitter @mukeshkapila